Antiviral Potential of Lactic Acid Bacteria and Their Bacteriocins

Probiotics and Antimicrobial Proteins

Volumn 6, Issue 3-4, 2014, Pages 177-185

  Al Kassaa, I ^a,b   Hober, D ^c   Hamze, M ^b   Chihib, N E ^a   Drider, D ^a  

^a Université de Lille 1 Sciences et Technologies   (France)

^b LEBANESE UNIVERSITY   (Lebanon)

^c University Lille   (France)

Author keywords

Antiviral agents; Bacteriocins; Lactic acid bacteria; Probiotics

Indexed keywords

ANTIVIRUS AGENT; BACTERIOCIN; PROBIOTIC AGENT;

ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; LACTOBACILLACEAE; VIRUS DISEASES;

ANIMALS; ANTIVIRAL AGENTS; BACTERIOCINS; HUMANS; LACTOBACILLACEAE; PROBIOTICS; VIRUS DISEASES;

EID: 84939893876     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-014-9162-6     Document Type: Review

References (69)

1. FAO/WHO (2002) Joint working group report on guidelines for the evaluation of probiotics in food. London, Ontario, Canada
2. Villena J, Oliveira ML, Ferreira P, Salva S, Alvarez S (2011) Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges. Int Immunopharmacol 11:1633–1645
3. Liu SQ (2003) Practical implications of lactate and pyruvate metabolism by lactic acid bacteria in food and beverage fermentations. Int J Food Microbiol 83:115–131
4. Belhadj H, Harzallah D, Khennouf S, Dahamna S, Bouharati S, Baghiani A (2010) Isolation, identification and antimicrobial activity of lactic acid bacteria from Algerian honeybee collected pollen. Acta Hort (ISHS) 854:51–58
5. Mercenier A, Pavan S, Pot B (2003) Probiotics as biotherapeutic agents. Curr Pharm Des 9:175–191
6. Harzallah D, Belhadj H (2013) Lactic acid bacteria as probiotics: characteristics, selection criteria and role in immunomodulation of human GI muccosal barrier Chapter 8. Book: 198 Lactic Acid Bacteria – R & D for Food, Health and Livestock Purposes, Inteck edition
7. Lakshmi B, Viswanath B, Sai Gopal DV (2013) Probiotics as antiviral agents in shrimp aquaculture. J Pathog 2013:424123. doi:10.1155/2013/424123
8. Seo BJ, Rather IA, Kumar VJ, Choi UH, Moon MR, Lim JH, Park YH (2012) Evaluation of Leuconostocmesenteroides YML003 as a probiotic against low-pathogenic avian influenza (H9N2) virus in chickens. J Appl Microbiol 113:163–171
9. Guarner F, Schaafsma GJ (1998) Probiotics. Int J Food Microbiol 17:237–238
10. Botić T, Klingberg TD, Weingartl H et al (2007) A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Int J Food Microbiol 115:227–234
11. Wang Z, Chai W, Burwinkel M, Twardziok S, Wrede P, Palissa C, Esch B, Schmid MFG (2013) Inhibitory influence of Enterococcusfaecium on the propagation of swine influenza a virus in vitro. PLoS One 8:e53043
12. Al Kassaa I, Hamze M, Hober D et al (2014) Identification of vaginal lactobacilli with potential probiotic properties isolated from women in North Lebanon. Microb Ecol 67:722–734
13. Kawashima T, Kyoko H, Akemi K, Megumi K et al (2011) Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses. Int Immunopharmacol 11:2017–2024
14. Klebanoff SJ, Coombs RW (1991) Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 174:289–292
15. Conti C, Malacrino C, Mastromarino P (2009) Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J Physiol Pharmacol 6:19–26
16. Martin LS, McDougal JS, Loskoski SL (1985) Disinfection and inactivation of the human lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis 152:400–403
17. Martin V, Maldonado A, Fernandez L, Rodriguez JM, Connor RI (2010) Inhibition of human immunodeficiency virus type 1 by lactic acid bacteria from human breastmilk. Breastfeed Med 5:153–158
18. Tuyama AC, Cheshenko N, Carlucci MJ, Li JH, Goldberg CL, Waller DP, Anderson RA, Profy AT, Klotman ME, Keller MJ, Herold BC (2006) Acidform inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations. J Infect Dis 194:795–803
19. Mastromarino P, Cacciotti F, Masci A, Mosca L (2011) Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: role of cell wall associated components. Anaerobe 17:334–336
20. Hill JA, Anderson DJ (1992) Human vaginal leukocytes and the effects of vaginal fluid lymphocyte and macrophage defense functions. Am J Obstet Gynecol 166:720–726
21. Ennahar S, Sashihara T, Sonomoto K, Ishizaki A (2000) Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol Rev 24:85–106
22. Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12:39–86
23. Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3:777–788
24. Abee T (1995) Pore-forming bacteriocins of Gram-positive bacteria and self-protection mechanisms of producer organisms. FEMS Microbiol Lett 129:1–10
25. Abee T, Krockel L, Hill C (1995) Bacteriocins: modes of action and potentials in food preservation and control of food poisoning. Int J Food Microbiol 28:169–185
26. Moll GN, Konings WN, Driessen AJM (1999) Bacteriocins: mechanism of membrane insertion and pore formation. Antonie Van Leeuwenhoek 76:185–198
27. Drider D, Rebuffat S (2011) Prokaryotic antimicrobial peptides: from genes to applications. Springer, New York, ISBN 9781441976918
28. Humaira Q, Sadia S, Ahmed S, Ajaz Rasool S (2006) Coliphage hsa as a model for antiviral studies/spectrum by some indigenous bacteriocin like inhibitory substances (BLIS). Pak J Pharma Sci 19:182–187
29. Saeed S, Rasool RA, Ahmad S, Zaidi SZ, Rehmani S (2007) Antiviral activity of Staphylococcin 188: a purified bacteriocin like inhibitory substance isolated from Staphylococcus aureus AB188. Res J Microbiol 2:796–806
30. Todorov SD, Wachsman M, Tomé E, Dousset X, Destro MT, Dicks LM, Franco BD, Vaz-Velho M, Drider D (2010) Characterisation of an antiviral pediocin-like bacteriocin produced by Enterococcus faecium. Food Microbiol 27:869–879
31. Wachsman MB, Farias ME, Takeda E, Sesma F, De Ruiz Holgado AP, de Torres RA, Coto CE (1999) Antiviral activity of enterocin CRL against herpes virus. Int J Antimicrob Agents 12:293–299
32. Todorov SD, Wachsman MB, Knoetze H, Meincken M, Dicks LMT (2005) An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4V isolated from soya beans. Int J Antimicrob Agents 25:508–513
33. Wachsman MB, Castilla V, De Ruiz Holgado AP, de Torres RA, Sesma F, Coto CE (2003) Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro. Antivir Res 58:17–24
34. Emiliano S, Lucila S, Fernando S (2007) Short peptides derived from the NH2-terminus of subclass IIa bacteriocin enterocin CRL35 show antimicrobial activity. J Antimicrob Chemother 59:1102–1108
35. Ishibashi N, Himeno K, Fujita K, Masuda Y, Perez RH, Zendo T, Wilaipun P, Leelawatcharamas V, Nakayama J, Sonomoto K (2012) Purification and characterization of multiple bacteriocins and an inducing peptide produced by Enterococcusfaecium NKR-5-3 from Thai fermented fish. Biosci Biotechnol Biochem 76:947–953
36. Férir G, Petrova M, Andrei G, Huskens D, Hoorelbeke B (2013) The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications. PLoS One 8:e64010
37. Serkedjieva J, Danova S, Ivanova I (2000) Antiinfluenza virus activity of a bacteriocin produced by Lactobacillus delbrueckii. Appl Biochem Biotechnol 88:122–129
38. Lehtoranta L, Pitkäranta A, Korpela R (2014) Probiotics in respiratory virus infections. Eur J Clin Microbiol Infect Dis. doi:10.1007/s10096-014-2086-y
39. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J (2010) Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr 103:58–68
40. Maeda N, Nakamura R, Hirose Y, Murosaki S, Yamamoto Y, Kase T, Yoshikai Y (2009) Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int Immunopharmacol 9:1122–1125
41. Boge T, Remigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27:5677–5684
42. Olivares M, Diaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonolla J, Navas M, Rodriguez JM, Xaus J (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23:254–260
43. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J (2006) Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24:6670–6674
44. Rautava S, Salminen S, Isolauri E (2009) Specific probiotics in reducing the risk of acute infections in infancy a randomised, double-blind, placebo-controlled study. Br J Nutr 101:1722–1726
45. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC (2009) Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124:e172–e179
46. Chiba E, Tomosada Y, Guadalupe MVP, Salva S (2013) Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection. Int Immunopharmacol 17:373–382
47. Salva S, Nuñez M, Villena J, Ramón A, Font G, Alvarez S (2011) Development of a fermented goats’ milk containing Lactobacillus rhamnosus: in vivo study of health benefits. J Sci Food Agric 91:2355–2362
48. Clancy R (2003) Immunobiotics and the probiotic evolution. FEMS Immunol Med Microbiol 38:9–12
49. Yasui H, Kiyoshima J, Hori T (2004) Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol 11:675–679
50. Kiso M, Takano R, Sakabe S, Katsura K, Shinya K, Uraki R (2013) Protective efficacy of orally administered, heat-killed Lactobacilluspentosus b240 against influenza A virus. Sci Rep 3:1563
51. Fong TT, Lipp EK (2005) Enteric viruses of humans and animals in aquatic environments: health risks, detection, and potential water quality assessment tools. Microbiol Mol Biol Rev 69:357–371
52. Farthing MJG (1989) Viruses and the gut. Smith Kline & French, Welwyn Garden City
53. Kocwa-Haluch R (2001) Waterborne enteroviruses as a hazard for human health. Pol J Environ Stud 10:485–487
54. Maragkoudakis PA, Chingwaru W, Gradisnik L, Tsakalidou E, Cencic A (2010) Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection. Int J Food Microbiol 141:S91–S97
55. Agarwal KN, Bhasin SK (2002) Feasibility studies to control acute diarrhea in children by feeding fermented milk preparations Actimel and Indian Dahi. Eur J Clin Nutr 56:S56–S59
56. Szajewska H, Mrukowicz JZ (2001) Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 33:S17–S25
57. Sarker SA, Sultana S, Fuchs GJ, Alam NH, Azim T, Brussow H, Hammarstrom L (2005) Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics 116:e221–e228
58. Cencic A, Chingwaru W (2010) The role of functional foods, Nutraceuticals, and food supplements in intestinal health. Nutrients 2:611–625
59. Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y (2004) Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104:3249–3256
60. UNAIDS, report on the global HIV/AIDS Epidemic 2000_: Executive Summary, UNAIDS, Genova Switzerland
61. Karim QA, Karim SSA, Frohlich JA et al (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329:1168–1174
62. Rubab Z, Baig S, Siddiqui A, Nayeem A, Salman S, Qidwai A, Mallick R, Qidwai S (2013) Human papilloma virus—role in precancerous and cancerous oral lesions of tobacco chewers. J Pak Med Assoc 63:10
63. Cha MK, Lee DK, An HM, Lee SW, Shin SH, Kwon JH, Kim KJ, Ha NJ (2012) Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16. BMC Med 10:72
64. Khania S, Motamedifara M, Golmoghaddam H, Hosseinic HM, Hashemizadeha Z (2012) In vitro study of the effect of a probiotic bacterium Lactobacillus rhamnosus against herpes simplex virus type 1. Braz J Infect Dis 16:129–135
65. Jaïdane H, Hober D (2008) Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab 34:537–548
66. Hober D, Sauter P (2010) Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 6:279–289
67. Qureshi TA, Mirbahar KB, Samo MU, Soomro NM, Solangi AA, Memon A (2006) Clinical study of experimentally induced anaphylactic shock in goats. Int J Pharmacol 2:357–361
68. Férir G, Petrova MI, Andrei G, Huskens D, Hoorelbeke B, Snoeck R, Vanderleyden J, Balzarini J, Bartoschek S, Brönstrup M, Süssmuth RD, Schols D (2013) The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications. PLoS One 8:e64010
69. Torres N, Sutyak N, Xu S, Li J, Huang Q, Sinko P (2013) Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1. Probiotics Antimicrob Proteins 5:26–35